Rebamipide is a gastroprotective agent widely used in the treatment of gastritis, gastric ulcers, and mucosal damage induced by non-steroidal anti-inflammatory drugs (NSAIDs). As demand for this API continues to grow across Asia, Europe, and emerging markets, pharmaceutical suppliers and exporters need accurate, up-to-date information about who is buying Rebamipide globally. This guide provides a structured overview of the Rebamipid global buyers list, covering key importing countries, active purchasers, and practical strategies for connecting with verified buyers. Understanding the Rebamipide Market Landscape Rebamipide is a white crystalline powder that functions by stimulating gastric mucus secretion, enhancing the mucosal barrier, and scavenging free radicals. The global Rebamipide drugs market was valued…